Report #2848766

Received Jul 7, 2025

ER / ED visit

A note on interpretation. VAERS reports are unverified and may be incomplete or coincidental. A report does not establish that a vaccine caused an event, and counts should not be used to calculate incidence or infer causation. Full disclaimer

Overview

Sex: Female
Age: 76 yrs
State: TX
Recovered: Unknown
Vaccinated: Jul 6, 2025
Onset: Jul 6, 2025
Days to onset: 0
Hospital days: —

Vaccines (2)

Type	Name	Manufacturer	Dose	Lot	Route / Site
PNC21	PNEUMO (CAPVAXIVE)	MERCK & CO. INC.	1	Z002626	IM / LA
VARZOS	ZOSTER (SHINGRIX)	GLAXOSMITHKLINE BIOLOGICALS	UNK	F95YS	IM / LA

Symptoms (3)

Injection site erythemaInjection site swellingPyrexia

Symptom narrative

Patient reported she developed a severe fever, injection site swelling and redness later in the day after being administered Shingrix and Capvaxive on 7/6/25 . Patient reported she was treated in emergency department on 7/6/25, since then most of her symptoms have resolved. She returned to pharmacy on 7/7/25 to report reaction, with leftover redness and swelling in injection site.